Search Results
Clinical Trial Spotlight: ALCHEMIST for Early-Stage ALK+ and EGFR Lung Cancer Patients
The Alchemist Lung Cancer Trials
Clinical Trial Spotlight: Determining Efficacy of Immunotherapy in Stage III Lung Cancer
Dr. Raz on the Impact of the ALCHEMIST Trial on the Treatment of Patients With Lung Cancer
Next Generation Clinical Trials in NSCLC (ALCHEMIST, MASTER, NCI MATCH, etc.)
GRACEcast-084_Lung-Cancer_ALK Inhibition: Science and Early Clinical Experience by Dr. Ben Solomon
Frontline ALK, EGFR Inhibition in Non-Small Cell Lung Cancer
Dr. Wakelee Discusses the Future of Lung Cancer Adjuvant Therapy
Targeted Therapies in a Post-Operative/Adjuvant Setting
Precision Medicine for Lung Cancer
Dr. Kim on Clinical Trial Eligibility Criteria in Lung Cancer
EGFR Breakout Video Targeted Therapies 2017
